Harout Semerjian is appointed CEO of Geron Corporation, while Immunomedics is acquired by Gilead.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Harout Semerjian is appointed CEO of Geron Corporation, while Immunomedics is acquired by Gilead.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Geron Corporation
company
Nothing else this week.
-
Gilead
ancient Israelite geographical location in modern day Jordan
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireGeron Appoints Harout Semerjian as President and Chief Executive Officer Industry veteran brings 30+ years of commercial hematology and oncology experience to help accelerate Geron’s next phase of gr